Difference between revisions of "Bupropion-escitalopram"

From Psychiatrienet
Jump to: navigation, search
(Redirected page to Bupropion-citalopram)
Line 1: Line 1:
#redirect [[Bupropion-citalopram]]
+
{{Drugswitch
 +
| from = bupropion
 +
| to = escitalopram
 +
| stop =
 +
* Gradually reduce dosage of bupropion to a maximum of 150 mg/ day.
 +
* When a dosage of 150 mg/day is reached, stop administration.
 +
| start =
 +
* No wash-out period is needed.
 +
* Start escitalopram the next day in normal dosage of 10 mg/day escitalopram.
 +
| info = 
 +
* Bupropion and its metabolites have long elimination times, so plasma concentrations will reduce gradually.
 +
}}

Revision as of 23:44, 4 March 2010

Bupropion
Type Antidepressant
Group other
links
ATC-code N06AX12
Medscape Bupropion
PubChem 444
PubMed Bupropion
Kompas (Dutch) Bupropion
Wikipedia Bupropion
Escitalopram
Type Antidepressant
Group SSRI
links
Medscape Escitalopram
PubChem 10832572
PubMed Escitalopram
Kompas (Dutch) Escitalopram
Wikipedia Escitalopram

Switch medication from bupropion to escitalopram.

Nietinrijdenbord.png Stop bupropion
  • Gradually reduce dosage of bupropion to a maximum of 150 mg/ day.
  • When a dosage of 150 mg/day is reached, stop administration.
Eenrichtingbord.png Start escitalopram
  • No wash-out period is needed.
  • Start escitalopram the next day in normal dosage of 10 mg/day escitalopram.
Infobord.png More information
  • Bupropion and its metabolites have long elimination times, so plasma concentrations will reduce gradually.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.